Creo Medical Group PLC (BST:1RC)

Market Cap	55.63M +5.3%
Revenue (ttm)	8.13M +62.8%
Net Income	-23.34M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1190
Previous Close	0.1190
Day's Range	0.1180 - 0.1190
52-Week Range	0.1050 - 0.2100
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 23, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablati...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 104
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 1RC

Financial Performance

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 10, 2026

Data Sources Report a data error